Uptake of the COVID-19 vaccine among healthcare workers in Malawi.
COVID-19
healthcare workers
vaccine hesitancy
vaccines
Journal
International health
ISSN: 1876-3405
Titre abrégé: Int Health
Pays: England
ID NLM: 101517095
Informations de publication
Date de publication:
03 01 2023
03 01 2023
Historique:
received:
11
10
2021
revised:
06
01
2022
accepted:
01
02
2022
pubmed:
17
3
2022
medline:
5
1
2023
entrez:
16
3
2022
Statut:
ppublish
Résumé
Little is known about coronavirus disease 2019 (COVID-19) vaccination in Africa. We sought to understand Malawian healthcare workers' (HCWs') COVID-19 vaccination and its hypothesized determinants. In March 2021, as the COVID-19 vaccine roll-out commenced in Malawi, we surveyed clinical and lay cadre HCWs (n=400) about their uptake of the vaccine and potential correlates (informed by the WHO Behavioral and Social Drivers of COVID-19 Vaccination framework). We analyzed uptake and used adjusted multivariable logistic regression models to explore how 'what people think and feel' constructs were associated with HCWs' motivation to be vaccinated. Of the surveyed HCWs, 82.5% had received the first COVID-19 vaccine dose. Motivation (eagerness to be vaccinated) was strongly associated with confidence in vaccine benefits (adjusted OR [aOR] 9.85, 95% CI 5.50 to 17.61) and with vaccine safety (aOR 4.60, 95% CI 2.92 to 7.23), but not with perceived COVID-19 infection risk (aOR 1.38, 95% CI 0.88 to 2.16). Of all the information sources about COVID-19 vaccination, 37.5% were reportedly negative in tone. HCWs in Malawi have a high motivation to be vaccinated and a high COVID-19 vaccine uptake. Disseminating vaccine benefits and safety messages via social media and social networks may be persuasive for individuals who are unmotivated to be vaccinated and less likely to accept the COVID-19 vaccine.
Sections du résumé
BACKGROUND
Little is known about coronavirus disease 2019 (COVID-19) vaccination in Africa. We sought to understand Malawian healthcare workers' (HCWs') COVID-19 vaccination and its hypothesized determinants.
METHODS
In March 2021, as the COVID-19 vaccine roll-out commenced in Malawi, we surveyed clinical and lay cadre HCWs (n=400) about their uptake of the vaccine and potential correlates (informed by the WHO Behavioral and Social Drivers of COVID-19 Vaccination framework). We analyzed uptake and used adjusted multivariable logistic regression models to explore how 'what people think and feel' constructs were associated with HCWs' motivation to be vaccinated.
RESULTS
Of the surveyed HCWs, 82.5% had received the first COVID-19 vaccine dose. Motivation (eagerness to be vaccinated) was strongly associated with confidence in vaccine benefits (adjusted OR [aOR] 9.85, 95% CI 5.50 to 17.61) and with vaccine safety (aOR 4.60, 95% CI 2.92 to 7.23), but not with perceived COVID-19 infection risk (aOR 1.38, 95% CI 0.88 to 2.16). Of all the information sources about COVID-19 vaccination, 37.5% were reportedly negative in tone.
CONCLUSIONS
HCWs in Malawi have a high motivation to be vaccinated and a high COVID-19 vaccine uptake. Disseminating vaccine benefits and safety messages via social media and social networks may be persuasive for individuals who are unmotivated to be vaccinated and less likely to accept the COVID-19 vaccine.
Identifiants
pubmed: 35294960
pii: 6549747
doi: 10.1093/inthealth/ihac007
pmc: PMC9808523
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
77-84Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
Références
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Sci Rep. 2021 Apr 12;11(1):7901
pubmed: 33846378
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
Prev Med. 2021 Sep;150:106694
pubmed: 34171345
Vaccine. 2013 Sep 23;31(41):4591-5
pubmed: 23896424
J Am Med Dir Assoc. 2021 Jun;22(6):1133-1137
pubmed: 33861978
Vaccine. 2018 Jan 29;36(5):660-667
pubmed: 29289384
Vaccines (Basel). 2021 Feb 19;9(2):
pubmed: 33669659
Lancet. 2021 Apr 3;397(10281):1265-1275
pubmed: 33773118
Health Policy. 2021 May;125(5):553-567
pubmed: 33820678
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
Vaccine. 2015 Mar 30;33(14):1748-55
pubmed: 25659278
Nat Commun. 2021 Jun 17;12(1):3698
pubmed: 34140469
N Engl J Med. 2021 May 20;384(20):1885-1898
pubmed: 33725432
Vaccine. 2020 Jun 26;38(31):4805-4815
pubmed: 32499068
Lancet Glob Health. 2021 Jun;9(6):e773-e781
pubmed: 33711262
Clin Infect Dis. 2022 Mar 9;74(5):882-890
pubmed: 34089598
Prev Med. 2021 Jul;148:106554
pubmed: 33857561
Lancet. 2020 May 2;395(10234):1405-1406
pubmed: 32243778
Vaccines (Basel). 2021 May 17;9(5):
pubmed: 34067682
Int J Environ Res Public Health. 2021 Apr 13;18(8):
pubmed: 33924451
Psychol Med. 2022 Oct;52(14):3127-3141
pubmed: 33305716
Vaccines (Basel). 2021 Feb 14;9(2):
pubmed: 33672938
Lancet Glob Health. 2021 Jun;9(6):e746-e748
pubmed: 33713633